Real-time enrollment status for this ampd3, omim*102772, amp deaminase deficiency clinical trial
Current Status
Recruiting
Checked: July 17, 2026 at 6:15 AM UTC
| NCT Number | NCT06092346 |
| Recruiting Status | Recruiting |
| Condition | AMPD3, OMIM*102772, AMP Deaminase Deficiency |
| Phase | Clinical Trial |
| Target Enrollment | 999 participants |
| Active Locations | 1 sites in the US |
| Sponsor | National Human Genome Research Institute (NHGRI) |
| Last Updated on CT.gov | September 4, 2025 (Sep 4, 2025) |
As of July 17, 2026: Clinical trial NCT06092346 is currently recruiting participants. This clinical trial study for ampd3, omim*102772, amp deaminase deficiency is actively seeking new participants at 1 location across the United States. The study is sponsored by National Human Genome Research Institute (NHGRI). This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06092346 is actively recruiting participants as of July 17, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06092346 was last updated Sep 4, 2025 (September 4, 2025). HelloStudys verifies this status automatically.